| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.09 | 0.05 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |